Michaela E. Arndt
Max Jarecki Str. 21
Heidelberg, BW 69115, Germany
Heidelberg, BW 69115, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Development of a highly effective combination monoclonal antibody therapy against Herpes simplex virus.
Journal: Journal of biomedical science
Published: December 20, 2023
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers.
Journal: Clinical and translational science
Published: May 16, 2022
Highly efficient destruction of squamous carcinoma cells of the head and neck by photochemical internalization of Ranpirnase.
Journal: Journal of experimental therapeutics & oncology
Published: January 16, 2017
Preclinical evaluation of a diabody-based (177)Lu-radioimmunoconjugate for CD22-directed radioimmunotherapy in a non-Hodgkin lymphoma mouse model.
Journal: Cancer letters
Published: May 06, 2016
High treatment efficacy by dual targeting of Burkitt's lymphoma xenografted mice with a (177)Lu-based CD22-specific radioimmunoconjugate and rituximab.
Journal: European journal of nuclear medicine and molecular imaging
Published: June 01, 2015
A Humanized Anti-CD22-Onconase Antibody-Drug Conjugate Mediates Highly Potent Destruction of Targeted Tumor Cells.
Journal: Journal of immunology research
Published: May 10, 2015
A fusogenic dengue virus-derived peptide enhances antitumor efficacy of an antibody-ribonuclease fusion protein targeting the EGF receptor.
Journal: Protein engineering, design & selection : PEDS
Published: October 11, 2014
Genetic delivery of an immunoRNase by an oncolytic adenovirus enhances anticancer activity.
Journal: International journal of cancer
Published: February 11, 2014
Generation of “LYmph Node Derived Antibody Libraries” (LYNDAL) for selecting fully human antibody fragments with therapeutic potential.
Journal: mAbs
Published: November 22, 2013
Overcoming drug-resistant herpes simplex virus (HSV) infection by a humanized antibody.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: April 10, 2013
Showing 1-11 of 11
Last Updated: 09/26/2026